News

Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
Zhang Xi, deputy dean and professor at the School of Cyberspace Security at the Beijing University of Posts and ...
Building public trust is essential for brands to cut through the noise, and storytelling is one of the most effective ways to do so. We live in an innovation age, and innovation leads to ...
Recursion Pharmaceuticals (NASDAQ:RXRX) stock is one of those lesser-known mid-cap biotech plays that investors may be ...
Score = Vlike × Plike + Vlove × Plove + Vangry × Pangry + Vcomment × Pcomment + Vshare × Pshare ...
Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...
A canonical problem in computer science is to find the shortest route to every point in a network. A new approach beats the ...
Discover how self-improving AI systems are redefining innovation, reshaping industries, and challenging our understanding of ...
Joan Is Awful dropped as the opener of Black Mirror Season 6.
B stacks up against GPT-4o in practical tests. From coding to logic and creativity, here’s the side-by-side you’ve been ...
Guest Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now The past few decades have seen almost ...